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Phenotypic analysis using heterologous host systems localized putative Bordetella pertussis ferric alcaligin
transport genes and Fur-binding sequences to a 3.8-kb genetic region downstream from the alcR regulator
gene. Nucleotide sequencing identified a TonB-dependent receptor family homolog gene, fauA, predicted to
encode a polypeptide with high amino acid sequence similarity with known bacterial ferric siderophore
receptors. In Escherichia coli, the fauA genes of both B. pertussis and Bordetella bronchiseptica directed the
production of a 79-kDa polypeptide, approximating the predicted size of the mature FauA protein. B. bron-
chiseptica fauA insertion mutant BRM17 was unable to utilize ferric alcaligin, and in complementation analyses
ferric alcaligin utilization was restored to this mutant by supplying the wild-type fauA gene in trans. Mutant
BRM18, carrying a nonpolar in-frame fauA deletion mutation, was defective in ferric alcaligin utilization and
55Fe-ferric alcaligin uptake and no longer produced a 79-kDa iron-regulated outer membrane protein. In
complementation analyses, BRM18 merodiploids bearing the wild-type fauA gene in trans regained ferric
alcaligin siderophore transport and utilization functions and produced the 79-kDa protein. Analysis of a
plasmid-borne fauA-lacZ operon fusion confirmed that fauA is subject to iron regulation at the transcriptional
level and that cis-acting transcriptional control elements mediating fauA iron repressibility reside within the
3.8-kb PstI fauA DNA region. Moreover, expression of the fauA-lacZ fusion gene under iron starvation condi-
tions was shown to be alcR dependent. FauA is a 79-kDa iron-regulated outer membrane receptor protein
required for transport and utilization of ferric alcaligin siderophore complexes by Bordetella species.
Under iron-limiting growth conditions, bacteria express
high-affinity transport systems to scavenge and assimilate nu-
tritional iron. These transport processes often involve the syn-
thesis and excretion of soluble siderophores that chelate ferric
iron and are subsequently conveyed into the bacterial cell by
ligand-specific cell surface receptors and permeases (34, 39).
To exploit the availability of diverse iron sources that may be
present in their environment, some microbes produce trans-
port proteins that enable them to utilize siderophores pro-
duced by other microbial species (18, 39). For all gram-nega-
tive bacteria examined to date, siderophore-mediated iron
uptake is dependent on the activities of TonB, ExbB, and
ExbD, which work in conjunction with the cognate outer mem-
brane receptor protein to translocate iron across the bacterial
outer membrane against a concentration gradient (37). Fur-
ther translocation of iron to the cytoplasm is accomplished by
a periplasmic binding protein and an ATP binding cassette
(ABC)-dependent permease in the cytoplasmic membrane.
Bordetella pertussis and Bordetella bronchiseptica are gram-
negative pathogens that inhabit the respiratory mucosae of
humans and nonhuman mammals. When nutritional iron is
limiting in availability, these organisms produce and utilize the
macrocyclic dihydroxamate siderophore alcaligin (16, 38). B.
pertussis and B. bronchiseptica are also capable of utilizing iron
complexed with the heterologous siderophores enterobactin
(8), ferrichrome, and desferrioxamine B (9). In addition to
siderophores, the mammalian host-derived molecules lactofer-
rin (1), transferrin (1, 26), hemin (9), and hemoglobin (40)
have been reported as iron sources for these bacteria. The
capacity of Bordetella cells to utilize these alternative iron
sources implies that they are capable of producing the cognate
transporters required for their utilization.
Biosynthesis of the alcaligin siderophore in B. pertussis and
B. bronchiseptica requires an ornithine decarboxylase activity
that yields the requisite alcaligin precursor putrescine from
ornithine (14). Dedicated alcaligin biosynthesis activities are
encoded within the iron-regulated alcABCDER operon (29,
30). AlcA, AlcB, and AlcC are required for alcaligin biosyn-
thesis; mutations in alcA, alcB, or alcC render Bordetella cells
unable to produce alcaligin (30). The alcA (25, 30), alcB, and
alcC gene products have strong primary amino acid sequence
similarity with the Escherichia coli aerobactin biosynthesis en-
zymes IucD, IucB, and IucC, respectively (19, 30). Based on
these amino acid sequence similarities and the known structure
of alcaligin, it is postulated that AlcA is an oxygenase that
catalyzes the hydroxylation of putrescine, and AlcB functions
in an acylation step involving succinate. AlcC is similar to IucC
aerobactin synthetase and may function in one of the final
reactions yielding alcaligin. AlcD was reported to have no
significant amino acid sequence similarity with any known pro-
teins, while AlcE has similarity to iron-sulfur-containing dioxy-
genases (43). Although their role in alcaligin biosynthesis has
not been established, the location of these two genes within the
alc biosynthesis operon and the prediction that AlcE may func-
tion as a dioxygenase suggest that alcD and alcE are also
involved in the biosynthesis of alcaligin. The alcR gene is in-
volved in the regulation of both alcaligin biosynthesis (11, 43)
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and transport of the ferric alcaligin complex (11). AlcR is an
AraC-like transcriptional regulator similar to the Pseudomonas
aeruginosa PchR pyochelin siderophore biosynthesis and trans-
port regulator protein (27) and the YbtA yersiniabactin sid-
erophore receptor gene regulator of Yersinia pestis (23). The
alcR gene is transcribed primarily from the Fur-regulated pro-
moter upstream from alcA as part of the alcABCDER operon
and is also transcribed from a secondary Fur-regulated pro-
moter located immediately upstream from alcR (11, 29). Ad-
jacent to alcR is an open reading frame predicted to encode a
multidrug efflux pump protein homolog (11, 43). This gene was
named bcr in a previous study (43) on the basis of amino acid
sequence similarity of the predicted product with the E. coli
bicyclomycin resistance efflux protein, Bcr. However, since ef-
flux pumps are generally not substrate specific (42) and the
function of the Bordetella protein remains unknown, we pres-
ently refer to this gene as orfX.
In the present study, we localized a Bordetella genetic region
downstream from orfX that is involved in ferric alcaligin trans-
port and identified the fauA gene encoding the ferric alcaligin
outer membrane receptor protein. FauA was localized in the
outer membrane fraction prepared from iron-starved B. bron-
chiseptica cells and was produced in E. coli by using an induc-
ible protein expression system. B. bronchiseptica fauA mutants
were unable to transport and utilize ferric alcaligin, and these
functions were restored to the mutants by genetic complemen-
tation using the cloned B. bronchiseptica or B. pertussis fauA
gene. Analysis of a fauA-lacZ operon fusion confirmed that
expression of fauA is regulated at the transcriptional level by
iron and by the AlcR regulator protein.
MATERIALS AND METHODS
Bacterial strains and culture conditions. B. bronchiseptica strains used in this
study are listed in Table 1. E. coli DH5a (Bethesda Research Laboratories,
Gaithersburg, Md.) was used as the host for routine plasmid propagation and
DNA cloning procedures and as the donor strain in triparental matings. E. coli
SURE (Stratagene, La Jolla, Calif.) was used for propagation of M13 mp18
bacteriophages (41), and E. coli host strain CJ236 (28) was used to produce
uracil-containing single-stranded M13 bacteriophage DNA for in vitro site-di-
rected mutagenesis procedures. E. coli S17-1(lpir) (36, 48) was the donor strain
for pUT mini-Tn5 lacZ1 suicide plasmids in transposon mutagenesis, and E. coli
K38(pGP1-2) was the host strain in bacteriophage T7 RNA polymerase/pro-
moter system protein expression studies (51). E. coli H1717 (fhuE-lacZ aroB)
served as the indicator host strain in Fur repressor titration assays (50) used to
identify potential Bordetella Fur-binding DNA sequences borne on multicopy
plasmids. Pyochelin- and pyoverdin-deficient P. aeruginosa mutant strain IA1 (5)
was used as a heterologous host for identification of genes encoding putative
Bordetella ferric alcaligin transport and utilization functions.
B. bronchiseptica and E. coli strains were grown in Luria-Bertani (LB) broth or
on LB agar plates (44). E. coli strains for bacteriophage T7 RNA polymerase/
promoter protein expression experiments were cultured in M9 medium (44)
supplemented with 0.2% glucose and 0.01% L-amino acids (minus cysteine and
methionine). Defined broth culture medium for Bordetella strains was Stainer-
Scholte medium (SS) (49) modified as described elsewhere (46); iron-replete SS
contained 36 mM FeSO4, and iron-depleted SS culture medium was prepared by
treatment of the medium with Chelex 100 (Bio-Rad, Hercules, Calif.) as de-
scribed by Armstrong and Clements (6). Growth was monitored as optical den-
sity, using a spectrophotometer or a Klett-Summerson colorimeter equipped
with a no. 54 filter (Klett Mfg. Co., Long Island City, N.Y.). Antibiotics were
used at the indicated concentrations: ampicillin, 100 mg/ml; chloramphenicol, 30
mg/ml; gentamicin, 10 mg/ml; kanamycin, 50 mg/ml; and nalidixic acid, 35 mg/ml.
Plasmids and genetic methods. Plasmid cloning vectors pGEM3Z (Promega,
Madison, Wis.), pBBR1MCS (31), and pBluescript II KS1 (Stratagene) were
used in the construction of recombinant plasmids. Recombinant Bordetella plas-
mids used in this study are listed in Table 1. Plasmid pRK2013 (24) was used to
provide transfer functions in triparental matings. Plasmid pBSL15 (3) was the
source of the kanamycin resistance gene used in the construction of B. bronchi-
septica insertion mutant BRM17. Suicide plasmid vectors pEG7 and pEG18.3 (2)
were used in allelic exchange procedures in the construction of B. bronchiseptica
mutant BRM18, and suicide plasmid pUT mini-Tn5 lacZ1 (20) was used to
generate fauA-lacZ transcriptional fusions.
General genetic techniques were performed essentially as described previously
(44). Verification of allelic exchange in Bordetella mutants was by Southern
hybridization analysis or PCR analysis of genomic DNA samples. DNA probes
used in nucleic acid hybridizations were radiolabeled by the random priming
method (22) using the Random Primers DNA labeling system (Gibco BRL,
Gaithersburg, Md.) and [a-32P]dCTP (ICN Radiochemicals, Irvine, Calif.). The
nucleotide sequence of fauA was determined for both DNA strands by using the
TABLE 1. Bordetella strains and plasmids used in this study
Strain or plasmid Relevant genotype or description Reference or source
B. bronchiseptica strains
B013N fauA1, nalidixic acid-resistant derivative of swine isolate strain B 6
BRM17 fauA1::Kanr mutant derivative of B013N, with an insertion of a 1.2-kb BamHI kanamycin
resistance cassette into the BglII restriction site in fauA
This study
BRM18 DfauA2 mutant derivative of B013N, with a nonpolar, in-frame deletion of 255 bp of
fauA coding sequences
This study
BRM11 DalcR1 mutant derivative of B013N 11
Recombinant plasmids
pCP1.11 B. pertussis strain UT25 fauA1 cosmid, source of sequenced fauA DNA, RK2 origin,
RK2-Mob1, RK2-Tra2, Tcr
30
pBRM6 20-kb fauA1 SalI genomic DNA fragment of B. bronchiseptica alcC mutant BRM6
cloned in pGEM3Z, Apr, ColE1 origin
6
p3Z44 7-kb B. bronchiseptica fauA1 EcoRI-SalI DNA fragment subcloned from pBRM6 to
pGEM3Z, Apr, ColE1 origin
This study
p3Z48 3.8-kb B. bronchiseptica fauA1 PstI DNA fragment subcloned from p3Z44 to pGEM3Z,
Apr, ColE1 origin
This study
p3Z49 As p3Z48 except opposite orientation of the 3.8-kb fauA1 PstI DNA insert fragment This study
pBB24 3.8-kb B. bronchiseptica fauA1 PstI DNA fragment subcloned from p3Z44 to
pBBR1MCS, Cmr
This study
pBB24DfauA As pBB24 except carrying the B. bronchiseptica DfauA2 mutant allele on the PstI DNA
insert fragment
This study
p3Z63 3.8-kb B. pertussis UT25 fauA1 PstI DNA fragment subcloned from pCP1.11 to
pGEM3Z, Apr, ColE1 origin
This study
p3Z69 As p3Z48 except carrying the B. bronchiseptica DfauA2 mutant allele on the PstI DNA
insert fragment
This study
pBB24/mini-Tn5 lacZ1 As pBB24 except carrying the B. bronchiseptica f(fauA9-lacZ1)1 allele generated by
mini-Tn5 lacZ1 transposon mutagenesis, Cmr, Kanr
This study
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dideoxy-chain termination method (45) and double-stranded plasmid DNA tem-
plates, with nucleotide sequencing services provided by the University of Ten-
nessee Molecular Biology Resource Facility and by the University of Minnesota
Microchemical Facility. Management and analysis of nucleotide sequence data
used the Lasergene sequence analysis software system for the Macintosh Pow-
erPC computer (DNASTAR, Inc., Madison, Wis.). Database searches and data
retrievals were performed by using the BLAST (4) server provided by the Na-
tional Center for Biotechnology Information at the National Library of Medi-
cine. Multiple amino acid sequence alignments were performed by the
CLUSTAL V method, using the MegAlign module of the Lasergene sequence
analysis software system (DNASTAR). Putative Bordetella Fur-binding se-
quences were identified by using the MegAlign software to locate DNA regions
of at least 50% identity over a 30-nucleotide search window with the dyad
sequence, 59-GATAATGATAATCATTATC-39, representing the proposed con-
sensus E. coli Fur-binding site (17, 21). Translated fauA DNA sequences were
scanned for the occurrence of PROSITE protein patterns by using the Scan-
Prosite tool of the ExPASy molecular biology server of the Swiss Institute of
Bioinformatics. Stained protein gels and protein gel autoradiographs were im-
aged by using a Hewlett Packard ScanJet 4c color flatbed scanner and Adobe
Photoshop LE software for the Power Macintosh computer.
Conjugal transfer of plasmids to Bordetella strains was accomplished as de-
scribed previously (14). Transformation of Bordetella or E. coli strains by elec-
troporation was performed by using standard methods (Bio-Rad).
The Fur repressor titration assay used to screen B. pertussis cosmid pCP1.11
fauA region subclones for functional Fur repressor-binding sequences was per-
formed as described by Stojiljkovic and coworkers (50), using lactose MacConkey
agar supplemented with 30 mM ferrous ammonium sulfate and appropriate
antibiotics to select for plasmid maintenance.
Construction of a B. bronchiseptica fauA insertion mutant. A fauA insertion
mutation was constructed by ligation of the 1.2-kb BamHI kanamycin resistance
cassette of plasmid pBSL15 into the unique BglII site of the B. bronchiseptica
DNA insert fragment of p3Z48. Since this plasmid is a ColE1 replicon and
unable to replicate in Bordetella strains, it was used as a suicide plasmid to deliver
the mutation to the B. bronchiseptica chromosome by homologous recombina-
tion. The plasmid was introduced into B. bronchiseptica wild-type strain B013N
by electroporation, and kanamycin-resistant clonal isolates were subsequently
screened for loss of the ampicillin resistance plasmid marker by replicate plating
on LB agar and LB agar containing ampicillin. Allelic exchange in B. bronchi-
septica mutant BRM17 was confirmed by Southern hybridization using fauA-
specific and plasmid vector DNA probes.
Construction of a B. bronchiseptica fauA deletion mutant. A nonpolar fauA
mutation was constructed by in vitro site-directed mutagenesis using the Kunkel
method (32), and the mutated fauA gene was introduced into wild-type B.
bronchiseptica strain B013N by allelic exchange. The purified 3.8-kb fauA PstI
DNA fragment of plasmid p3Z49 was ligated with PstI-digested bacteriophage
M13 mp18 replicative-form DNA, and the ligation mixture was used to transfect
E. coli host strain SURE. Recombinant bacteriophages bearing the 3.8-kb PstI B.
bronchiseptica DNA insert fragment were plaque purified and used to infect E.
coli host strain CJ236. Bacteriophages were recovered from infected CJ236
culture supernatants by polyethylene glycol-NaCl precipitation, and single-
stranded uracil-containing bacteriophage DNA was purified by using standard
procedures. The mutagenic 42-mer oligonucleotide fau1 (59-TTGCCCGAGCC
TGTCATCAGGGATTGTGGTGTTTCGCGTGGC-39) is complementary to
two noncontiguous regions of the fauA sense strand, spanning the site of the
desired deletion mutation. This primer was phosphorylated using T4 polynucle-
otide kinase and ATP, annealed to the single-stranded uracil-containing fauA
template DNA, and extended by using T7 DNA polymerase and deoxyribonu-
cleotides in the presence of T4 DNA ligase. A portion of the resulting reaction
mixture was used to transfect E. coli SURE, and replicative-form DNA samples
isolated from plaque-purified bacteriophage progeny were mapped by using the
unique EcoRV and BglII restriction endonuclease sites in fauA that flank the
desired mutation. Bacteriophage DNA samples from phage clones produced
from two independent mutagenesis reactions were sequenced to confirm the
desired deletion of fauA coding sequences.
The sacBR positive selection allelic exchange system of Akerley and coworkers
(2) was used to cross the fauA deletion mutation carried on the 3.8-kb fauA PstI
DNA fragment into the chromosome of wild-type B. bronchiseptica strain B013N.
Deletion mutations were verified by PCR analysis of genomic DNA samples
prepared from putative DfauA mutants, using oligonucleotide primers 59-GAC
ACTCTCGCCACGCGAAAC-39 (upstream primer) and 59-CGTGATGGGCA
CGGAGATGTC-39 (downstream primer) flanking the chromosomal deletion
mutation. Based on the known fauA nucleotide sequence, these primers were
predicted to direct the synthesis of a 430-bp PCR product from the wild-type
fauA region and a 175-bp PCR product from DfauA mutants. Agarose gel
electrophoresis was used to determine the sizes of PCR reaction products cor-
responding to the presence of wild-type or DfauA mutant alleles in the bacterial
chromosome.
Measurement of Bordetella siderophore activity. The chrome azurol S univer-
sal siderophore detection assay (47) was used to quantitate alcaligin production
by Bordetella cells grown in iron-depleted SS as described previously (6, 16) to
monitor iron nutritional status of bacteria. Siderophore assays were performed in
triplicate.
Ferric alcaligin utilization bioassays. Growth stimulation of B. bronchiseptica
strains and siderophore-deficient P. aeruginosa mutant strain IA1 by ferric al-
caligin siderophore complexes was measured by quantitative ferric alcaligin uti-
lization bioassays using iron-restricted agar plates containing ethylenediaminedi-
[(o-hydroxyphenyl)acetic acid] (EDDA) at a concentration of 100 mg/ml,
performed as described previously (11, 16). Alcaligin siderophore was purified
from spent Bordetella culture supernatants as described by Brickman and co-
workers (16) and used at aqueous concentrations of 250, 125, and 63 mg/ml.
Ferric alcaligin transport assays. B. bronchiseptica cells were assayed for the
ability to bind and transport ferric alcaligin by measuring 55Fe(III) accumulation
by the method of Langman et al. (33) as modified by Brickman and coworkers
(16), using 55Fe(III) supplied as 5 mM alcaligin–3.3 mM 55Fe(III) complexes (3:2
molar ratio, pH 8.0). Cell-associated 55Fe counts per minute were measured by
scintillation counting.
Production of plasmid-encoded FauA proteins in E. coli. Plasmid-encoded
FauA proteins were conditionally produced in E. coli K38(pGP1-2) by using the
bacteriophage T7 polymerase/promoter system of Tabor and Richardson (51).
After induction of fauA expression at mid-logarithmic growth phase by incuba-
tion at 42°C, approximately 5 3 107 cells (0.1 units of optical density at 600 nm)
were harvested by centrifugation, solubilized in sodium dodecyl sulfate-polyac-
rylamide gel electrophoresis (SDS-PAGE) sample buffer at 100°C for 7 min and
analyzed by SDS-PAGE on 10% polyacrylamide gels. Proteins were visualized by
intrinsic radiolabeling using Tran35S-label (ICN Biochemicals, Inc.), SDS-
PAGE, and autoradiography of dried electrophoretic gels.
Cell fractionation and SDS-PAGE. Bordetella cells from iron-replete and iron-
depleted SS cultures were harvested by centrifugation at late-logarithmic growth
phase, resuspended in 50 mM HEPES buffer (pH 7.4), and lysed by passage
through a French pressure cell (American Instrument Company, Silver Spring,
Md.). The insoluble cell fraction sediment obtained by ultracentrifugation was
extracted with Triton X-100 detergent as described previously (46), and the outer
membrane protein-enriched detergent-insoluble fraction was resuspended in 50
mM HEPES buffer (pH 7.4) and solubilized in SDS-PAGE sample buffer at
100°C for 7 min. Proteins were resolved by SDS-PAGE on 7.5 or 10% polyacryl-
amide gels containing 0.5 M urea as described previously (46), with approxi-
mately 20 mg of protein applied to each lane. Protein bands were visualized by
staining with Coomassie blue dye.
Construction and analysis of a fauA-lacZ transcriptional fusion plasmid.
Transposon mini-Tn5 lacZ1 (20) was delivered to B. bronchiseptica B013N car-
rying fauA plasmid pBB24 by conjugal transfer of suicide plasmid pUT mini-Tn5
lacZ1 from donor strain E. coli S17-1(lpir). After 5 h of mating on an LB agar
plate surface, bacterial growth was harvested and total plasmid DNA was pre-
pared by the alkaline lysis method (12). Plasmid DNA pools were used to
transform E. coli DH5a to kanamycin and chloramphenicol resistance, and
mutated pBB24 plasmids subsequently isolated from transformants were
screened by restriction endonuclease mapping for insertions in fauA. Plasmids
carrying fauA insertions in the fauA sense orientation were transferred to wild-
type B. bronchiseptica strain B013N and alcR mutant strain BRM11 by conjuga-
tion. Transconjugants were assayed for b-galactosidase activity by the method of
Miller (35) as modified by Brickman et al. (15) after culture in iron-replete or in
iron-depleted SS medium.
Nucleotide sequence accession number. The GenBank accession number as-
signed to the B. pertussis UT25 fauA gene is AF135154.
RESULTS
Preliminary identification of putative ferric alcaligin trans-
port and utilization genes and Fur-binding sequences by phe-
notypic analysis using heterologous host systems. Since micro-
bial siderophore system genes are usually clustered on the
chromosome, it was hypothesized that alcaligin transport genes
may reside near known alcaligin biosynthesis genes on B. per-
tussis cosmid pCP1.11 or on the adjacent overlapping cosmids
described previously (30). Prior alcaligin biosynthesis studies
using a heterologous host system established that pyochelin-
and pyoverdin-deficient P. aeruginosa mutant strain IA1 (5)
carrying pCP1.11 produced authentic alcaligin (10). In parallel
studies using mutant strain IA1 as a host system for expression
of potential Bordetella alcaligin transport and utilization genes,
analysis of subcloned segments of pCP1.11 identified an ap-
proximately 4-kb PstI genetic region downstream from alcR
(Fig. 1) that conferred a positive growth stimulation phenotype
to IA1 in bioassays using purified alcaligin as an iron source
(data not shown). When cloned to high-copy-number plasmids,
the same B. pertussis genetic region had strong in vivo Fur
repressor-binding activity by the Fur repressor titration assay
in E. coli (data not shown), consistent with the presence of
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previously unidentified functional Fur repressor-binding se-
quences. Based on these preliminary data suggesting the existence
of previously unknown ferric alcaligin transport and utilization
genes and functional Fur-binding sequences downstream from
alcR, the corresponding DNA region was further analyzed by
nucleotide sequencing.
Nucleotide sequencing of putative ferric alcaligin transport
and utilization genes. Complete nucleotide sequence analysis
of an approximately 3-kb genetic region downstream from alcR
identified a large open reading frame encoding a putative B.
pertussis TonB-dependent receptor family homolog. In
BLASTP searches, the GenBank database sequences produc-
ing the six highest-scoring alignments with the deduced Borde-
tella receptor homolog (GenBank accession no. AF135154)
were ferric siderophore receptor proteins. These included the
ferripyoverdin receptor FpvA of P. aeruginosa (GenBank ac-
cession no. U07359), the Pseudomonas putida ferric
pseudobactin 358 receptor PupA (GenBank accession no.
P25184), the E. coli FhuE outer membrane receptor for ferric
coprogen, ferric ferrioxamine B, and ferric rhodotorulic acid
(GenBank accession no. P16869), the P. putida PupB ferric
pseudobactin BN7/BN8 receptor (GenBank accession no.
P38047), P. aeruginosa ferric pyochelin receptor FptA (Gen-
Bank accession no. P42512), and PbuA, the ferric pseudobac-
tin M114 receptor of Pseudomonas sp. strain M114 (GenBank
accession no. Q08017). Overall percent similarity between the
Bordetella ferric siderophore receptor homolog and these high-
est-scoring database retrievals ranged from 33.1% for FpvA to
27.0% for PbuA at the primary amino acid sequence level.
The Bordetella ferric siderophore receptor homolog gene
was tentatively named fauA, for ferric alcaligin uptake gene. As
deduced from the nucleotide sequence, the FauA precursor
protein is a 734-amino-acid polypeptide with a calculated mo-
lecular mass of approximately 81.6 kDa. A PROSITE database
search revealed that at C-terminal amino acid positions 717 to
734, FauA exhibits the TonB-dependent receptor protein sig-
nature 2 (PROSITE PDOC00354) that is characteristic of
most other members of the TonB-dependent receptor family
(Fig. 2). Consistent with the earlier identification of functional
Fur-binding DNA sequences in the fauA genetic region by Fur
repressor titration assay, a computer-predicted Fur repressor-
binding site, 59-AAAAAAGATAATTCCTATT-39, was iden-
tified at nucleotide positions 35 to 50 upstream from the start
of the fauA coding sequence (Fig. 1).
Beginning approximately 300 bp downstream from the end
of the fauA coding region and extending to the PstI terminus of
the sequenced DNA region (Fig. 1) is a partial open reading
frame encoding a polypeptide with primary amino acid se-
quence similarity to multiple antibiotic resistance protein
MarC of E. coli (GenBank accession no. P31123) and Salmo-
nella typhimurium (GenBank accession no. Q56068). MarC
proteins are members of SwissProt uncharacterized protein
family UPF0056 of integral membrane proteins. This Borde-
tella marC-like gene, tentatively named mar, is transcribed in
the same polarity as fauA, but it is not yet known whether it is
FIG. 1. Spatial organization of known Bordetella alcaligin siderophore system genes. The 20-kb XhoI insert DNA fragment of B. pertussis cosmid pCP1.11 is depicted
at the top. The enlarged map in the center represents an approximately 12-kb BamHI-PstI subregion of pCP1.11; arrows indicate the direction of transcription and
genetic limits of all known genes within the Bordetella alcaligin gene cluster, and open circles represent known or hypothetical Fur-regulated promoter-operator regions.
The detailed lowermost map is enlarged to represent the 3.8-kb PstI DNA subregion encoding fauA, and a 1-kb scale bar is shown. FBS indicates the position of the
computer-predicted Fur-binding site immediately upstream from the start of the fauA coding sequences. The approximate position of sequences complementary to
mutagenic primer fau1 used in the construction of DfauA mutant BRM18 is indicated by the small arrow. The triangle indicates the position of the BglII site of insertion
of the kanamycin resistance cassette (Kanr) in fauA mutant BRM17. Abbreviations: X, XhoI; B, BamHI; E, EcoRI; Sp, SphI; P, PstI; Sm, SmaI; K, KpnI; RV, EcoRV;
Bg, BglII.
FIG. 2. Partial amino acid sequence alignments of FauA with TonB-depen-
dent bacterial siderophore receptor proteins of high similarity. (A) Multiple
sequence alignments of the FauA C terminus with C termini of bacterial sid-
erophore receptor proteins producing the six highest-scoring alignments with
FauA in GenBank database searches (GenBank accession numbers: P. aerugi-
nosa FpvA, U07359; P. putida PupA, P25184; E. coli FhuE, P16869; P. putida
PupB, P38047; P. aeruginosa FptA, P42512; Pseudomonas sp. strain M114 PbuA,
Q08017). With the exceptions of residues Q717 and Y734 of FauA and T812 of
FpvA (boxed), all amino acid residues shown are consistent with the PROSITE
database TonB-dependent receptor protein signature 2 (PROSITE
PDOC00354) consensus pattern (B) shared by most members of the TonB-
dependent receptor family.
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operonic with fauA or whether it encodes any function related
to iron metabolism.
Construction and analysis of B. bronchiseptica fauA inser-
tion mutant BRM17. To preliminarily address the hypothe-
sized role of fauA in transport and utilization of ferric alcaligin,
fauA insertion mutant BRM17 was constructed by insertion of
a kanamycin resistance cassette at the unique BglII site of fauA
(Fig. 1). In growth stimulation bioassays, BRM17 was fully
defective in utilization of ferric alcaligin as an iron source
(Table 2). Genetic complementation of BRM17 by the wild-
type 3.8-kb B. bronchiseptica PstI fauA DNA region as plasmid
pBB24 resulted in restoration of ferric alcaligin utilization. In
these complementation analyses, BRM17 carrying multicopy
fauA plasmids reproducibly displayed larger growth haloes
than the wild-type indicator strain, presumably because of
FauA overproduction and enhanced ferric alcaligin utilization.
Complementation of the BRM17 ferric alcaligin utilization
defect by B. bronchiseptica plasmids carrying the 3.8-kb PstI
fauA DNA region was independent of insert DNA orientation
with respect to the plasmid cloning vector (data not shown),
suggesting that fauA was expressed from a natural Bordetella
promoter borne on that plasmid construct. In addition, a B.
pertussis fauA plasmid carrying the 3.8-kb PstI fauA DNA re-
gion (Fig. 1) was equally capable of restoring ferric alcaligin
utilization to BRM17 (data not shown), indicating that the B.
pertussis fauA gene was fully functional in B. bronchiseptica by
this growth stimulation bioassay method.
Construction of a B. bronchiseptica fauA deletion mutant. A
specific fauA deletion mutation was constructed in vitro, and
the mutated B. bronchiseptica fauA gene was crossed into wild-
type B. bronchiseptica strain B013N by allelic exchange as de-
scribed in Materials and Methods. The mutation was designed
to generate an in-frame deletion removing 255 bp (85 codons)
of fauA coding sequences that specify a FauA segment (amino
acid residues 89 to 173 in the FauA precursor protein) that is
highly conserved among known TonB-dependent outer mem-
brane siderophore complex receptors; thus, the deleted se-
quences were hypothesized to encode a region of functional
importance in the FauA protein. Further, an in-frame deletion
was desired in order to avoid potential polarity effects of a
mutation on unknown, potentially cotranscribed downstream
genes that may also be involved in ferric alcaligin transport or
utilization.
After in vitro mutagenesis of cloned fauA sequences, bacte-
riophage DNA from clones produced from two independent
mutagenesis reactions was sequenced, and both were found to
carry the desired deletion mutation. To preliminarily assess the
phenotypic effect of the mutation, the mutated fauA PstI frag-
ment was subcloned to the broad-host-range plasmid vector
pBBR1MCS to produce pBB24DfauA, and this plasmid was
introduced into B. bronchiseptica fauA insertion mutant
BRM17, which is defective in ferric alcaligin utilization. Unlike
the wild-type fauA plasmid equivalent pBB24, mutated plas-
mid pBB24DfauA was unable to complement the growth defect
of BRM17 when supplied with ferric alcaligin in growth stim-
ulation bioassays (Table 2). These data were consistent with
the prediction that the fauA deletion mutation would ulti-
mately result in a functionally defective FauA protein once
transferred to the B. bronchiseptica chromosome by allelic ex-
change.
A positive selection allelic exchange system (2) was used to
cross the fauA deletion mutation into the chromosome of wild-
type B. bronchiseptica strain B013N, and the allelic exchange
was confirmed by genomic PCR analysis. Electrophoretic anal-
ysis of PCR products generated from genomic DNA samples
prepared from four putative B013N DfauA mutants by using
oligonucleotide primers flanking the deletion junction revealed
that three of the four putative mutants carried only the DfauA
allele (data not shown). The fourth putative B013N DfauA
mutant carried only a wild-type fauA allele, yielding a single
PCR product indistinguishable from that produced from a
wild-type control genomic DNA template.
FauA requirement for growth stimulation by ferric alcaligin
siderophore. The three B013N DfauA mutants identified by
genomic PCR analysis were assayed for growth stimulation by
ferric alcaligin under iron starvation culture conditions using
bioassays conducted in parallel with the wild-type parent strain
B013N. Consistent with the results of physical mapping of the
chromosomal fauA regions by genomic PCR analysis, the de-
letion mutants examined in growth stimulation bioassays were
fully defective in ferric alcaligin transport or utilization com-
pared with the wild-type control strain. One B013N DfauA
mutant chosen for further study was designated BRM18 (Table
1). In complementation analyses, growth stimulation by ferric
alcaligin in bioassays was restored to BRM18 by the wild-type
B. bronchiseptica fauA gene supplied as plasmid pBB24 (Table
2). As in BRM17 complementation analyses, growth stimula-
tion zones for the complemented BRM18 DfauA mutant were
consistently larger than those produced with wild-type indica-
tor cells. BRM18 growth stimulation by ferric alcaligin was also
restored by plasmids carrying the analogous wild-type 3.8-kb
PstI fauA genetic region of B. pertussis strain UT25 (Fig. 1),
indicating that the fauA alleles of the two different Bordetella
species are interchangeable in this functional assay (data not
shown). These growth stimulation bioassays confirmed the pre-
dicted correlation between the deletion mutation detected by
genomic PCR mapping and a defective ferric alcaligin trans-
port or utilization phenotype. Genetic complementation re-
sults confirmed that ferric alcaligin utilization could be fully
restored to BRM18 by the wild-type fauA gene of either B.
pertussis or B. bronchiseptica in trans.
FauA requirement for ferric alcaligin-mediated iron trans-
port. B. bronchiseptica DfauA mutant BRM18 and the wild-
type parent strain B013N were assayed for the ability to trans-
port iron supplied as 55Fe(III)-alcaligin complexes. Iron
transport by iron-starved Bordetella cells was monitored as the
accumulation of cell-associated 55Fe (Fig. 3). Compared with
wild-type B013N iron transport activity, DfauA mutant strain
BRM18 carrying the pBBR1MCS control plasmid vector was
grossly defective in 55Fe uptake. Consistent with the results of
TABLE 2. Utilization of ferric alcaligin by wild-type and mutant B.
bronchiseptica strainsa
Indicator strain
Growth zone (mm) surrounding wells
containing purified alcaligin at concn of:
63 mg/ml 125 mg/ml 250 mg/ml
B013N (wild type) 16 20 24
BRM17 — — —
BRM17(pBBR1MCSb) — — —
BRM17(pBB24DfauA) — — —
BRM17(pBB24) 17 22 27
BRM18 — — —
BRM18(pBBR1MCS) — — —
BRM18(pBB24) 18 23 28
a Aqueous alcaligin solution (50 ml/well) at the indicated concentration was
added to 6-mm-diameter wells in EDDA-containing iron-restricted agar medium
seeded with indicator strains, and diameters of growth zones were measured
after 18 h incubation at 37°C. No growth occurred in the absence of added
alcaligin siderophore. —, no detectable growth stimulation.
b Plasmid vector control.
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the growth stimulation bioassays, B. bronchiseptica fauA plas-
mid pBB24 complemented the BRM18 ferric alcaligin trans-
port defect, restoring accumulation of cell-associated 55Fe to
wild-type levels. Although cell-associated 55Fe levels for the
complemented mutant are not significantly different from the
wild-type level, mathematical curve fitting indicated that the
initial 55Fe uptake rate for the complemented mutant was
greater than the wild-type rate, possibly reflecting a higher
receptor density at the cell surface.
Bacteriophage T7 promoter-directed FauA protein produc-
tion. Protein production directed by the 3.8-kb Bordetella PstI
fauA DNA region was examined by using a bacteriophage T7
RNA polymerase/promoter expression system in E. coli (Fig.
4). In the fauA sense orientation with respect to the plasmid
vector T7 gene 10 promoter, both B. pertussis and B. bronchi-
septica 3.8-kb PstI DNA regions directed the production of a
single strongly radiolabeled polypeptide migrating at an appar-
ent molecular mass of approximately 79 kDa. These products
approximate the predicted size (ca. 77.7 kDa) of the mature
FauA protein, based on amino acid sequence comparisons of
FauA with processed forms of similar ferric siderophore re-
ceptor proteins. The cloned B. bronchiseptica DfauA region
directed the production of a smaller polypeptide with an ap-
parent molecular mass of approximately 69 kDa, consistent
with the loss of an 85-amino-acid segment resulting from the
DfauA in-frame deletion.
FauA protein production in B. bronchiseptica. In this and
previous SDS-PAGE analyses (11, 13), a polypeptide with an
apparent molecular mass of approximately 79 kDa was de-
tected in whole-cell lysates and outer membrane-enriched frac-
tions of B013N cultured under iron-depleted conditions. The
79-kDa iron-regulated outer membrane protein was not
present at detectable levels in samples prepared from B. bron-
chiseptica DfauA mutant BRM18 but was very strongly pro-
duced under iron-depleted culture conditions by BRM18 car-
rying wild-type fauA plasmid pBB24 (Fig. 5). Production of this
79-kDa iron-regulated outer membrane protein correlates with
the ability of fauA plasmid pBB24 to restore ferric alcaligin
growth stimulation and 55Fe-alcaligin uptake to mutant
BRM18. The protein has an apparent molecular mass consis-
tent with predictions based on the fauA nucleotide sequence
and appears indistinguishable from wild-type FauA proteins
produced in T7 protein expression experiments in E. coli. El-
evated levels of FauA detected in outer membrane prepara-
tions of BRM18 carrying wild-type fauA plasmid pBB24 cor-
relate with enhanced ferric alcaligin growth stimulation
observed in bioassays for fauA mutants BRM17 and BRM18
complemented with this plasmid.
Iron regulation and alcR-dependent expression of a fauA-
lacZ transcriptional fusion gene. Fifteen mini-Tn5 lacZ1 trans-
poson insertions were mapped to fauA sequences in plasmid
pBB24 by restriction endonuclease mapping. One insertion
chosen for further analysis mapped near the center of fauA,
approximately 900 bp downstream from the start of the fauA
coding sequence. The orientation of this transposon insertion
in the fauA sense placed lacZ reporter gene transcription un-
der the control of any putative fauA regulatory sequences
FIG. 3. Bordetella 55Fe-ferric alcaligin transport assays. The rate of uptake of
the 55Fe label of 55Fe-ferric alcaligin by iron-starved B. bronchiseptica wild-type
strain B013N (squares), DfauA mutant BRM18 (diamonds), and DfauA mutant
BRM18 carrying wild-type fauA plasmid pBB24 (circles), using an alcaligin
concentration of 5 mM, together with 3.3 mM 55Fe(III) is shown over a 7-min
period of time. Mean 55Fe counts per minute 6 standard deviations (n 5 3) are
plotted as a function of time.
FIG. 4. Production of Bordetella FauA polypeptides, using a bacteriophage
T7 RNA polymerase/promoter expression system in E. coli. Intrinsically labeled
plasmid-encoded FauA proteins were resolved by SDS-PAGE and visualized by
autoradiography. Whole-cell lysates of E. coli K38(pGP1-2) containing p3Z63
(B. pertussis 3.8-kb PstI fauA fragment; Bp fauA), p3Z48 (B. bronchiseptica 3.8-kb
PstI fauA fragment; Bb fauA), p3Z69 (B. bronchiseptica 3.8-kb PstI DfauA frag-
ment deleted of the 255-bp internal fauA region; Bb DfauA), and pGEM3Z
(plasmid vector control; Control) are shown. U, uninduced; I, induced for ex-
pression of T7 promoter-directed genes by temperature shift and in the presence
of rifampin. Positions of marker proteins are given along with their apparent
molecular masses in kilodaltons. The radiolabeled FauA products are indicated
by arrows.
FIG. 5. SDS-PAGE analysis of iron-regulated FauA outer membrane pro-
tein production in B. bronchiseptica. FauA outer membrane protein production
by wild-type B. bronchiseptica B013N, DfauA mutant BRM18, and DfauA mutant
BRM18 carrying wild-type fauA plasmid pBB24 was analyzed by SDS-PAGE.
Outer membrane proteins were visualized by staining gels with Coomassie blue
dye. 1, outer membrane proteins from iron-replete cells; 2, outer membrane
proteins from iron-depleted cells. Arrowheads indicate positions of the 79-kDa
FauA protein in the wild-type B013N and BRM18(pBB24) outer membrane
samples. Positions of marker proteins are given along with their apparent mo-
lecular masses in kilodaltons.
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present on the 3.8-kb PstI fauA insert DNA fragment of
pBB24. The fusion plasmid, pBB24/mini-Tn5 lacZ1, was trans-
ferred to wild-type B. bronchiseptica strain B013N and isogenic
alcR mutant strain BRM11 by conjugation, and fauA transcrip-
tional activity was monitored as b-galactosidase reporter gene
activity of cells cultured under iron-replete versus iron-de-
pleted conditions in SS defined medium. In this plasmid con-
text in wild-type B. bronchiseptica strain B013N, fauA tran-
scriptional activity was elevated nearly fivefold by iron
starvation (Fig. 6). Analysis of the fauA-lacZ fusion gene in
alcR mutant strain BRM11 revealed that fauA transcription
was dependent on the regulatory gene alcR; expression of the
fauA fusion gene in the alcR mutant was drastically reduced.
The apparent requirement of alcR for fauA expression is con-
sistent with the previously observed loss of production of an
iron-repressible 79-kDa membrane protein by B. bronchisep-
tica alcR mutants BRM10 and BRM11 (11). The alcR mutant
BRM10, which is also defective in alcaligin production, was
identified in a screening for ferric alcaligin transport mutants
on the basis of a ferric alcaligin utilization-defective pheno-
type. These data indicate that fauA transcription is iron regu-
lated and alcR dependent and that cis-acting transcriptional
control elements are active within the pBB24 plasmid-borne
fauA DNA region.
DISCUSSION
In our previous report of the purification and spectroscopic
analysis of alcaligin produced by B. pertussis and B. bronchi-
septica, evidence for biological activity of the purified alcaligin
siderophore was obtained by using growth stimulation bioas-
says and quantitative ferric alcaligin transport assays with Bor-
detella indicator strains (16). Uptake rates and saturability of
iron uptake observed in quantitative ferric alcaligin transport
assays were consistent with the involvement of a high-affinity
receptor-mediated ferric alcaligin transport system and pro-
vided the first direct evidence of iron delivery to Bordetella cells
mediated by the native alcaligin siderophore. Despite the dem-
onstration of rapid and saturable transport of iron supplied as
ferric alcaligin, the specific outer membrane receptor for ferric
alcaligin or other potential alcaligin transport proteins re-
mained unidentified.
The first Bordetella ferric siderophore receptor identified
was the B. pertussis BfeA receptor for the heterologous sid-
erophore ferric enterobactin (8), found in a screen of E. coli to
detect iron-repressible genes encoding exported proteins.
BfeA was found to share a high degree of similarity with the
ferric enterobactin receptors FepA of E. coli and PfeA of P.
aeruginosa, and growth stimulation by ferric enterobactin was
shown to be defective in B. pertussis and B. bronchiseptica bfeA
mutants. Later, using the same E. coli screening approach, the
putative ferric siderophore receptor gene bfrA was identified in
B. bronchiseptica (9). The bfrA gene was repressible by Fur and
iron and was predicted to encode an 80-kDa outer membrane
protein with strong similarity with members of the TonB-de-
pendent outer membrane receptor family, especially with Cir
of E. coli and IrgA of Vibrio cholerae, and with three known
ferric enterobactin receptors. In phenotypic analyses, Borde-
tella bfrA mutants were found to be unaffected in their ability
to utilize ferric alcaligin, ferric enterobactin, and 2,3-dihy-
droxybenzoylserine. 2,3-Dihydroxybenzylserine utilization was
shown to be dependent on the Bordetella ferric enterobactin
receptor BfeA. Ferrichrome, desferrioxamine B, and hemin
were shown to stimulate Bordetella growth, albeit by mecha-
nisms functioning independently of both the BfeA and BfrA
proteins in B. bronchiseptica and B. pertussis. The specificity of
bfrA and its potential role in iron transport remain unknown.
Two additional Fur-regulated ferric siderophore receptor ho-
mologs of unknown specificity, bfrB and bfrC, have since been
identified in B. bronchiseptica (7). B. bronchiseptica and B.
pertussis bfrB and bfrC mutants and a B. bronchiseptica bfrB
bfrC double mutant had no phenotypic defects related to
growth stimulation by any known Bordetella iron sources. Since
phenotypic characterization of ferric siderophore receptor ho-
molog mutants determined that BfrA, BfrB, and BfrC are not
involved in the utilization of any known Bordetella iron sources,
these data suggest that the iron-scavenging potential of Borde-
tella species may include additional, unidentified iron sources.
With the exception of BfeA, it has proven difficult to predict
the specificity of the putative Bordetella siderophore receptors
based on nucleotide sequence information. Recent analysis of
B. pertussis and B. bronchiseptica tonB mutants confirmed that
as with other characterized gram-negative bacteria, TonB func-
tion is required for specific utilization of all known iron sources
by these species (40).
In this study, the hypothesis that previously unknown Bor-
detella ferric alcaligin siderophore transport genes might be
clustered near known alcaligin biosynthesis genes was tested by
screening for B. pertussis genes encoding ferric alcaligin utili-
zation functions in a heterologous host system. We identified a
3.8-kb PstI genetic region mapping immediately downstream
from the known alcaligin system gene alcR that conferred a
strong positive ferric alcaligin growth stimulation phenotype to
siderophore-deficient P. aeruginosa IA1, an indicator strain
that is normally incapable of ferric alcaligin utilization. The
ability of the fauA gene alone to confer a ferric alcaligin utili-
zation phenotype to IA1 implies that IA1 is capable of supply-
ing any additional transport and utilization activities required
for growth stimulation by ferric alcaligin. Nucleotide sequenc-
ing of the region identified a putative ferric siderophore re-
ceptor gene, fauA, with deduced primary amino acid sequence
similarity with known members of the TonB-dependent recep-
tor family. The fauA DNA regions of B. pertussis UT25 and B.
bronchiseptica B013N each directed the production of a 79-
kDa protein in E. coli, approximating the predicted size of the
mature FauA protein.
Functional Fur repressor-binding sequences were detected
on the 3.8-kb PstI DNA fragment by the Fur repressor titration
assay in E. coli. Analysis of a plasmid-borne fauA-lacZ operon
fusion in wild-type B. bronchiseptica provided evidence of iron
regulation of fauA at the transcriptional level, mediated by
FIG. 6. Iron regulation and alcR-dependent expression of a fauA-lacZ tran-
scriptional fusion gene. Transcriptional activity of a fauA-lacZ fusion gene car-
ried as plasmid pBB24/mini-Tn5 lacZ1 in wild-type B. bronchiseptica B013N
(alcR1) or isogenic alcR mutant strain BRM11 (alcR mutant) was assessed by
measuring b-galactosidase activity of bacteria cultured under iron-replete ( n )
and iron-depleted (h) conditions. Mean b-galactosidase activities 6 standard
deviations (n 5 3) are shown in Miller units.
5964 BRICKMAN AND ARMSTRONG J. BACTERIOL.
cis-acting control elements residing within the 3.8-kb PstI fauA
DNA region. By using an alcR mutant host strain, transcription
of the fauA-lacZ fusion gene was also shown to be alcR de-
pendent, an effect that is consistent with the previous obser-
vation of alcR-dependent production of an unidentified 79-
kDa membrane protein, presumably FauA, in phenotypic
analysis of B. bronchiseptica alcR mutants (11). A previous
report also described a 79-kDa protein that was normally iron
regulated but constitutively produced by a B. bronchiseptica fur
mutant (13). Complete genetic characterization of fauA regu-
lation will require further analysis.
Presumptive evidence for the requisite role of fauA in ferric
alcaligin utilization was obtained by phenotypic analysis of B.
bronchiseptica fauA insertion mutant BRM17. BRM17 was in-
capable of utilizing ferric alcaligin in growth stimulation bio-
assays, and in complementation analyses ferric alcaligin utili-
zation was restored to BRM17 by the wild-type fauA gene of
either B. pertussis or B. bronchiseptica supplied in trans. The
ability of the fauA gene alone to complement the ferric alcali-
gin utilization defect of BRM17 when supplied in trans sug-
gested that the BRM17 mutant phenotype was not due to
polarity effects of the insertion mutation. However, to test the
requirement for FauA function in ferric alcaligin transport and
utilization in the absence of potential polarity effects of inser-
tion mutations on any downstream genes, a nonpolar in-frame
fauA deletion mutation was crossed into B. bronchiseptica
B013N to produce DfauA mutant BRM18. BRM18 was defec-
tive in ferric alcaligin utilization in growth stimulation bioas-
says and in iron transport activity using quantitative 55Fe-ferric
alcaligin uptake assays. BRM18 also failed to produce detect-
able quantities of a 79-kDa iron-regulated outer membrane
protein produced by the wild-type parent strain B013N. In
complementation studies, BRM18 merodiploids carrying a
wild-type fauA gene in trans regained ferric alcaligin transport
and utilization capacity, and production of the 79-kDa iron-
regulated outer membrane protein was restored.
Genetic and biochemical evidence presented in this report
corroborates and extends our previous observations of produc-
tion of a 79-kDa outer membrane protein regulated by Fur and
AlcR (11, 13), the ferric alcaligin utilization defect associated
with alcR mutants (11), and the rapid and saturable transport
of ferric alcaligin siderophore complexes by B. bronchiseptica
(16). The fauA gene encodes the iron-regulated outer mem-
brane receptor protein required for ferric alcaligin transport
and utilization. Further studies will be necessary to identify
additional gene products involved in transport and utilization
of ferric alcaligin by Bordetella species.
ACKNOWLEDGMENTS
We thank Peggy Cotter, Jeff F. Miller, Igor Stojiljkovic, Bob An-
kenbauer, and Victor de Lorenzo for bacterial strains and plasmids.
We acknowledge Chantel Sabus and Jessica Boeldt for technical as-
sistance. We are grateful to Cari Vanderpool for assistance with ferric
alcaligin transport assays, FauA expression studies, and Bordetella cell
fractionation and for helpful discussions and critical reading of the
manuscript.
This work was supported by Public Health Service grant AI-31088
from the National Institute of Allergy and Infectious Diseases.
REFERENCES
1. Agiato, L.-A., and D. W. Dyer. 1992. Siderophore production and membrane
alterations by Bordetella pertussis in response to iron starvation. Infect. Im-
mun. 60:117–123.
2. Akerley, B. J., P. A. Cotter, and J. F. Miller. 1995. Ectopic expression of the
flagellar regulon alters development of the Bordetella-host interaction. Cell
80:611–620.
3. Alexeyev, M. F. 1995. Three kanamycin resistance gene cassettes with dif-
ferent polylinkers. BioTechniques 18:52–56.
4. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990.
Basic local alignment search tool. J. Mol. Biol. 215:403–410.
5. Ankenbauer, R., S. Sriyosachati, and C. D. Cox. 1985. Effects of sid-
erophores on the growth of Pseudomonas aeruginosa in human serum and
transferrin. Infect. Immun. 49:132–140.
6. Armstrong, S. K., and M. O. Clements. 1993. Isolation and characterization
of Bordetella bronchiseptica mutants deficient in siderophore activity. J. Bac-
teriol. 175:1144–1152.
7. Beall, B. 1988. Two iron-regulated putative ferric siderophore receptor genes
in Bordetella bronchiseptica and Bordetella pertussis. Res. Microbiol. 149:189–
201.
8. Beall, B., and G. N. Sanden. 1995. A Bordetella pertussis fepA homologue
required for utilization of exogenous ferric enterobactin. Microbiology 141:
3193–3205.
9. Beall, B., and T. Hoenes. 1997. An iron-regulated outer-membrane protein
specific to Bordetella bronchiseptica and homologous to ferric siderophore
receptors. Microbiology 143:135–145.
10. Beaumont, F. C., and S. K. Armstrong. 1995. A heterologous expression
system for the genetic analysis of Bordetella siderophore synthesis, abstr.
B-361, p. 228. In Abstracts of the 95th General Meeting of the American
Society for Microbiology 1995. American Society for Microbiology, Wash-
ington, D.C.
11. Beaumont, F. C., H. Y. Kang, T. J. Brickman, and S. K. Armstrong. 1998.
Identification and characterization of alcR, a gene encoding an AraC-like
regulator of alcaligin siderophore biosynthesis and transport genes in Bor-
detella pertussis and Bordetella bronchiseptica. J. Bacteriol. 180:862–870.
12. Birnboim, H. C., and J. Doly. 1979. A rapid alkaline extraction procedure for
screening recombinant plasmid DNA. Nucleic Acids Res. 7:1513–1523.
13. Brickman, T. J., and S. K. Armstrong. 1995. Bordetella pertussis fur gene
restores iron-repressibility of siderophore and protein expression to dereg-
ulated Bordetella bronchiseptica mutants. J. Bacteriol. 177:268–270.
14. Brickman, T. J., and S. K. Armstrong. 1996. The ornithine decarboxylase
gene odc is required for alcaligin siderophore biosynthesis in Bordetella spp.:
putrescine is a precursor of alcaligin. J. Bacteriol. 178:54–60.
15. Brickman, T. J., B. A. Ozenberger, and M. A. McIntosh. 1990. Regulation of
divergent transcription from the iron-responsive fepB-entC promoter-oper-
ator regions in Escherichia coli. J. Mol. Biol. 212:669–682.
16. Brickman, T. J., J.-G. Hansel, M. J. Miller, and S. K. Armstrong. 1996.
Purification, spectroscopic analysis, and biological activity of the macrocyclic
dihydroxamate siderophore alcaligin produced by Bordetella pertussis and
Bordetella bronchiseptica. BioMetals 9:191–203.
17. Calderwood, S. B., and J. J. Mekalanos. 1987. Iron regulation of Shiga-like
toxin expression in Escherichia coli is mediated by the fur locus. J. Bacteriol.
169:4759–4764.
18. Crosa, J. H. 1997. Signal transduction and transcriptional and posttranscrip-
tional control of iron-regulated genes in bacteria. Microbiol. Mol. Biol. Rev.
61:319–336.
19. de Lorenzo, V., A. Bindereif, B. H. Paw, and J. B. Neilands. 1986. Aerobactin
biosynthesis and transport genes of plasmid ColV-K30 in Escherichia coli
K-12. J. Bacteriol. 165:570–578.
20. de Lorenzo, V., M. Herrero, U. Jakubzik, and K. N. Timmis. 1990. Mini-Tn5
transposon derivatives for insertion mutagenesis, promoter probing, and
chromosomal insertion of cloned DNA in gram-negative eubacteria. J. Bac-
teriol. 172:6568–6572.
21. de Lorenzo, V., S. Wee, M. Herrero, and J. B. Neilands. 1987. Operator
sequences of the aerobactin operon of plasmid ColV-K30 binding the ferric
uptake regulation (fur) repressor. J. Bacteriol. 169:2624–2630.
22. Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA
restriction endonuclease fragments to high specific activity. Anal. Biochem.
132:6–13.
23. Fetherston, J. D., S. W. Bearden, and R. D. Perry. 1996. YbtA, an AraC-type
regulator of the Yersinia pestis pesticin/yersiniabactin receptor. Mol. Micro-
biol. 22:315–325.
24. Figurski, D. H., and D. R. Helinski. 1979. Replication of an origin-containing
derivative of plasmid RK2 dependent on a plasmid function provided in
trans. Proc. Natl. Acad. Sci. USA 76:1648–1652.
25. Giardina, P. C., L.-A. Foster, S. I. Toth, B. A. Roe, and D. W. Dyer. 1995.
Identification of alcA, a Bordetella bronchiseptica gene necessary for alcaligin
production. Gene 167:133–136.
26. Gorringe, A. R., G. Woods, and A. Robinson. 1990. Growth and siderophore
production by Bordetella pertussis under iron-restricted conditions. FEMS
Microbiol. Lett. 66:101–106.
27. Heinrichs, D. E., and K. Poole. 1993. Cloning and sequence analysis of a
gene (pchR) encoding an AraC family activator of pyochelin and ferripyoch-
elin receptor synthesis in Pseudomonas aeruginosa. J. Bacteriol. 175:5882–
5889.
28. Joyce, C. M., and N. D. F. Grindley. 1984. Method for determining whether
a gene of Escherichia coli is essential: application to the polA gene. J.
Bacteriol. 158:636–643.
29. Kang, H. Y., and S. K. Armstrong. 1998. Transcriptional analysis of the
Bordetella alcaligin siderophore biosynthesis operon. J. Bacteriol. 180:855–
861.
VOL. 181, 1999 BORDETELLA FERRIC ALCALIGIN SIDEROPHORE RECEPTOR 5965
30. Kang, H. Y., F. C. Beaumont, T. J. Brickman, and S. K. Armstrong. 1996.
Identification and characterization of iron-regulated Bordetella pertussis al-
caligin siderophore biosynthesis genes. J. Bacteriol. 178:4877–4883.
31. Kovach, M. E., R. W. Phillips, P. H. Elzer, R. M. Roop II, and K. M.
Peterson. 1994. pBBR1MCS: a broad-host-range cloning vector. BioTech-
niques 16:800–802.
32. Kunkel, T. A. 1985. Rapid and efficient site-specific mutagenesis without
phenotypic selection. Proc. Natl. Acad. Sci. USA 82:488–492.
33. Langman, L., I. G. Young, G. E. Frost, H. Rosenberg, and F. Gibson. 1972.
Enterochelin system of iron transport in Escherichia coli: mutations affecting
ferric-enterochelin esterase. J. Bacteriol. 112:1142–1149.
34. Lankford, C. E. 1973. Bacterial assimilation of iron. Crit. Rev. Microbiol.
2:273–331.
35. Miller, J. H. 1972. Experiments in molecular genetics, p. 352–355. Cold
Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
36. Miller, V. L., and J. J. Mekalanos. 1988. A novel suicide vector and its use
in construction of insertion mutations: osmoregulation of outer membrane
proteins and virulence determinants in Vibrio cholerae requires toxR. J.
Bacteriol. 170:2575–2583.
37. Moeck, G. S., and J. W. Coulton. 1998. TonB-dependent iron acquisition:
mechanisms of siderophore-mediated active transport. Mol. Microbiol. 28:
675–681.
38. Moore, C. H., L.-A. Foster, D. G. Gerbig, D. W. Dyer, and B. W. Gibson.
1995. Identification of alcaligin as the siderophore produced by Bordetella
pertussis and Bordetella bronchiseptica. J. Bacteriol. 177:1116–1118.
39. Neilands, J. B. 1981. Microbial iron compounds. Annu. Rev. Biochem. 50:
715–731.
40. Nicholson, M. L., and B. Beall. 1999. Disruption of tonB in Bordetella bron-
chiseptica and Bordetella pertussis prevents utilization of ferric siderophores,
haemin and haemoglobin as iron sources. Microbiology 145:2453–2462.
41. Norrander, J., T. Kempe, and J. Messing. 1983. Construction of improved
M13 vectors using oligodeoxynucleotide-directed mutagenesis. Gene
26:101–106.
42. Paulsen, I. T., M. H. Brown, and R. A. Skurray. 1996. Proton-dependent
multidrug efflux systems. Microbiol. Rev. 60:575–608.
43. Pradel, E., N. Guiso, and C. Locht. 1998. Identification of AlcR, an AraC-
type regulator of alcaligin siderophore synthesis in Bordetella bronchiseptica
and Bordetella pertussis. J. Bacteriol. 180:871–880.
44. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a
laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor,
N.Y.
45. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with
chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463–5467.
46. Schneider, D. R., and C. D. Parker. 1982. Effect of pyridines on phenotypic
properties of Bordetella pertussis. Infect. Immun. 38:548–553.
47. Schwyn, B., and J. B. Neilands. 1987. Universal chemical assay for the
detection and determination of siderophores. Anal. Biochem. 160:47–56.
48. Simon, R., U. Priefer, and A. Puhler. 1983. A broad host range mobilization
system for in vivo genetic engineering: transposon mutagenesis in Gram
negative bacteria. Bio/Technology 1:784–791.
49. Stainer, D. W., and M. J. Scholte. 1970. A simple chemically defined medium
for the production of phase I Bordetella pertussis. J. Gen. Microbiol. 63:211–
220.
50. Stojiljkovic, I., A. J. Baumler, and K. Hantke. 1994. Fur regulon in
gram-negative bacteria. Identification and characterization of new iron-
regulated Escherichia coli genes by a Fur titration assay. J. Mol. Biol.
236:531–545.
51. Tabor, S., and C. C. Richardson. 1985. A bacteriophage T7 RNA polymer-
ase/promoter system for controlled exclusive expression of specific genes.
Proc. Natl. Acad. Sci. USA 82:1074–1078.
5966 BRICKMAN AND ARMSTRONG J. BACTERIOL.
